Sign in
4

Changes in Ownership

Immunovant, Inc. Filed Acc 0001764013-25-000138

Chief Technology Officer sold 1,585 shares at $16.30 ($25,836)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stout Jay S Chief Technology Officer 2025-10-08 Sale −1,585 $16.30 $25,836 203,334 D
Open-market sales · 1,585 sh · avg $16.30 · $25,836
Loading xslF345X05/wk-form4_1760126514.xml…